David Knieriem v. Group Health Plan

CourtCourt of Appeals for the Eighth Circuit
DecidedJanuary 19, 2006
Docket05-1139
StatusPublished

This text of David Knieriem v. Group Health Plan (David Knieriem v. Group Health Plan) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
David Knieriem v. Group Health Plan, (8th Cir. 2006).

Opinion

United States Court of Appeals FOR THE EIGHTH CIRCUIT ___________

No. 05-1139 ___________

David Knieriem, as personal * representative of the Estate of * Troy Siade, deceased, * * Appellant, * * Appeal from the United States v. * District Court for the * Eastern District of Missouri. Group Health Plan, Inc.; * Bernard Mansheim, * * Appellees. * ___________

Submitted: October 12, 2005 Filed: January 19, 2006 ___________

Before RILEY, HANSEN, and COLLOTON, Circuit Judges. ___________

RILEY, Circuit Judge.

David Knieriem (Knieriem), as personal representative of the estate of Troy Siade (Siade), appeals the order of the district court1 dismissing his claim, because the relief sought against Siade’s employer-sponsored health care plan was not available

1 The Honorable Audrey G. Fleissig, United States Magistrate Judge for the United States District Court for the Eastern District of Missouri, presiding by consent of the parties pursuant to 28 U.S.C. § 636(c)(1). under the Employee Retirement Income Security Act of 1974 (ERISA), § 502(a)(3)(B), 29 U.S.C. § 1132(a)(3)(B). We affirm.

I. BACKGROUND Siade had an employer-sponsored health care plan provided by Group Health Plan, Inc. (GHP). The plan was governed by ERISA. GHP issued the health insurance policy for the plan. In 2001, Siade was diagnosed with non-Hodgkin’s lymphoma and sought GHP’s pre-approval for an allogeneic stem cell transplant. GHP denied coverage on the basis the procedure was “investigational and unproven” and therefore excluded under the plan’s policy.

In April 2004, following GHP’s denial of coverage, Siade filed a lawsuit in Missouri state court seeking damages against GHP and Dr. Bernard Mansheim, Chief Medical Officer of Coventry Health Care, GHP’s parent company (collectively, GHP). Siade alleged GHP’s wrongful denial of coverage amounted to medical malpractice and intentional infliction of emotional distress under Missouri law. GHP removed the case to federal court based on ERISA preemption. The district court denied Siade’s motion to remand, finding the state claims were preempted by ERISA, but granted Siade leave to file an amended complaint to plead a claim under ERISA.

In his amended complaint, Siade2 requested a jury trial and alleged GHP breached its fiduciary duty by denying coverage. For relief, Siade requested the court “order restitution by defendants to Plaintiff; to award Plaintiff a ‘surcharge’ as that term was used in equity prior to the fusion of law and equity; to provide compensation to Plaintiff for defendants’ breach of fiduciary duty; [and] to award attorney’s fees.” GHP then moved to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6) for failure to state a claim under ERISA. The district court granted the motion, reasoning

2 Siade passed away shortly after the case was removed. Knieriem was appointed personal representative of Siade’s estate. The district court permitted Knieriem to be substituted as plaintiff, and allowed Knieriem to serve as both personal representative and counsel in this action. -2- “[w]hile Plaintiff has phrased his request as for ‘restitution’ and a ‘surcharge for breach of a fiduciary duty,’ Plaintiff is actually seeking monetary relief, and such relief is not available under ERISA.”

On appeal, Knieriem argues the district court erred in dismissing the claim because ERISA allows a monetary award of restitution and a surcharge to the beneficiaries of a decedent when the plan administrator improperly fails to authorize a procedure.

II. DISCUSSION We review de novo the district court’s grant of a motion to dismiss pursuant to Rule 12(b)(6), accepting all factual allegations in the complaint as true and granting every reasonable inference in favor of the nonmovant. MM&S Fin., Inc. v. Nat’l Ass’n of Sec. Dealers, Inc., 364 F.3d 908, 909 (8th Cir. 2004) (citing Stone Motor Co. v. GMC, 293 F.3d 456, 464 (8th Cir. 2002)). “A motion to dismiss should be granted only if it appears beyond doubt that the plaintiff can prove no set of facts to warrant a grant of relief.” Gilmore v. County of Douglas, Neb., 406 F.3d 935, 937 (8th Cir. 2005) (citing Carter v. Arkansas, 392 F.3d 965, 968 (8th Cir. 2004)).

There is no dispute Siade did not receive the allogeneic stem cell transplant. We will assume, as we must in reviewing a dismissal for failure to state a claim, GHP breached its fiduciary duty by denying coverage for the procedure. The question before us is whether the requested relief is available under ERISA.

Knieriem does not deny the relief requested is money damages. Instead, he contends ERISA’s roots in the equitable law of trusts allow for monetary damages in the present case. First, Knieriem argues, as a fiduciary, GHP held the money Siade paid for health benefits in trust. Therefore, recovery is nothing more than the restitution of the funds the fiduciary had an obligation to release. Knieriem’s second argument is monetary recovery in the form of a surcharge is available as an equitable

-3- remedy when, as here, a trustee has gained personally from wrongful action taken in managing a trust. We disagree.

A. Restitution As the Supreme Court has oft-iterated, “ERISA is a comprehensive and reticulated statute, the product of a decade of congressional study of the Nation’s private employee benefit system.” Great-West Life & Annuity Ins. Co. v. Knudson, 534 U.S. 204, 209 (2002) (internal quotations omitted). The Court similarly has repeated its reluctance “‘to tamper with [the] enforcement scheme’ embodied in the statute by extending remedies not specifically authorized by its text.” Id. (quoting Mass. Mut. Life Ins. Co. v. Russell, 473 U.S. 134, 147 (1985)) (alteration in original). The statute’s failure to include certain remedies, as the Court has noted, was not an oversight; rather, “ERISA’s carefully crafted and detailed enforcement scheme provides strong evidence that Congress did not intend to authorize other remedies that it simply forgot to incorporate expressly.” Id. (internal quotations omitted). Vague notions that ERISA’s purpose would be defeated if recovery was limited are inadequate to overcome the basic words of the statute. Mertens v. Hewitt Assocs., 508 U.S. 248, 261 (1993); Kerr v. Charles F. Vatterott & Co., 184 F.3d 938, 943 (8th Cir. 1999).

ERISA’s civil enforcement provision, found in section 1132, lists six types of civil actions that may be pursued for violations of the statute. See Russell, 473 U.S. at 139-40. The present case was brought pursuant to section 1132(a)(3), which allows a civil action, “by a participant, beneficiary, or fiduciary . . . (B) to obtain other appropriate equitable relief (i) to redress such violations or (ii) to enforce any provisions of . . . the terms of the plan.” 29 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
David Knieriem v. Group Health Plan, Counsel Stack Legal Research, https://law.counselstack.com/opinion/david-knieriem-v-group-health-plan-ca8-2006.